Metaplastic breast carcinomas (MPBC) are rare, aggressive and relatively chemorefractory
tumors with a high unmet need. While most are “triple negative” and lack expression of …

Metaplastic breast cancer (MpBC) is an uncommon aggressive malignancy that is
associated with a poor prognosis. Due to its rarity, the relationships between the clinical and …

Abstract Objective Metaplastic breast cancer (MetaBC) is a rare breast cancer subtype
poorly responsive to systemic therapy in the metastatic setting with high recurrence rates in …

Background Metaplastic breast carcinoma (MBC) is a rare, aggressive subtype of breast
cancer associated with poorer overall survival than other triple-negative breast cancers. This …

Aims High‐grade metaplastic breast carcinoma (HG‐MBC) is a rare subtype of invasive
breast carcinoma, mostly triple‐negative. Metaplastic carcinomas are less responsive to …

Purpose: Metaplastic breast cancer (BC) is an uncommon yet aggressive histologic subtype
of BC. We sought to identify factors associated with its diagnosis and compare the …

Objectives Metaplastic breast cancer (MBC) is a rare neoplasm accounting for< 1% of all
breast cancer. We evaluated the clinical characteristics and survival outcomes of MBC …

Introduction. Metaplastic breast carcinoma is a rare special type of breast cancer, which has
distinguished clinical characteristics. We aimed to evaluate the clinicopathological features …

Introduction Neoadjuvant chemotherapy (NAC) for breast cance has not been well studied
for metaplastic breast cancer (MBC), a rare but aggressive type of breast cancer. Materials …

Purpose Metaplastic breast cancer (MBC) is a rare, aggressive form of breast cancer with
limited data to guide management. This study of a large, contemporary US database …